找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Universalising Healthcare in India; From Care to Coverag Imrana Qadeer,K. B. Saxena,P. M. Arathi Book 2021 The Editor(s) (if applicable) an

[復(fù)制鏈接]
樓主: morphology
11#
發(fā)表于 2025-3-23 12:18:16 | 只看該作者
12#
發(fā)表于 2025-3-23 16:09:45 | 只看該作者
13#
發(fā)表于 2025-3-23 19:46:27 | 只看該作者
Interrogating the Proposed Universal Healthcare in India Through a ‘Quality’ LensRising health inequalities, catastrophic healthcare costs pushing people below the poverty line, along with glaring gaps between economic growth rates and health status of people have raised many questions about the post-liberalisation health sector reforms in India.
14#
發(fā)表于 2025-3-24 02:12:25 | 只看該作者
15#
發(fā)表于 2025-3-24 03:23:29 | 只看該作者
Role of Public Private Partnerships in Ensuring Universal Healthcare for IndiaIn the early 1990s Health Sector Reforms (HSR) undertaken as part of structural adjustment programmes proposed a range of changes in governance, provisioning, financing and resource generation.
16#
發(fā)表于 2025-3-24 06:31:07 | 只看該作者
17#
發(fā)表于 2025-3-24 12:00:51 | 只看該作者
Universal Healthcare and Universalising Health Insurance: Examining the Binary Through the RSBY/MSBYThe Rashtriya Swasthya Bima Yojana (RSBY) is a state-funded health insurance scheme in India, targeted at families living Below Poverty Line (BPL).
18#
發(fā)表于 2025-3-24 15:14:42 | 只看該作者
Aarogyasri Scheme in Andhra Pradesh, India: Some Critical ReflectionsUniversal Health Coverage (UHC) is currently being debated all over the world and the ruling Bharatiya Janata Party (BJP) government in India has now brought in the idea of health assurance.
19#
發(fā)表于 2025-3-24 20:36:06 | 只看該作者
20#
發(fā)表于 2025-3-25 01:04:48 | 只看該作者
Drugs and Vaccines in Healthcare: Problems and PossibilitiesThe problems with regard to the use of allopathic drugs in India range from quality and regulation to irrational use because of the nexus between pharmaceutical companies and the largely commercial healthcare establishments. Fake or sub-standard allopathic drugs may represent as much as 25% of our drugs.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-19 17:45
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
赞皇县| 江陵县| 新津县| 肇州县| 桂阳县| 西青区| 黑河市| 当雄县| 宝山区| 兴文县| 汨罗市| 大安市| 新丰县| 南澳县| 溧阳市| 莱阳市| 东源县| 繁峙县| 信丰县| 忻城县| 南皮县| 望江县| 仙居县| 田林县| 天峻县| 惠东县| 江西省| 黄梅县| 合水县| 澎湖县| 肇庆市| 武冈市| 甘洛县| 丹寨县| 沿河| 杂多县| 奇台县| 哈巴河县| 新民市| 清水河县| 肇州县|